文献速递消化系统肿瘤

加拿大采用OncoSim模型评估降低推荐结直肠癌筛查起始年龄与癌症发病率、死亡率和费用的关联

Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim.
PubMed 文献 · JAMA Oncol · 2023-01-01

该经济评价计算研究使用OncoSim微模拟模型,纳入4个出生队列(1973-1977、1978-1982、1983-1987、1988-1992),评估将每两年一次粪便免疫化学检测(FIT)筛查起始年龄从50岁降至45岁或40岁与结直肠癌发病率、死亡率和医疗费用的关联。结果显示,45岁起始筛查较50岁起始可减少12 188例结直肠癌病例、5 261例结直肠癌死亡,并增加92 112个质量调整生命年(QALY);40岁起始筛查则减少18 135例病例、7 988例死亡,增加150 373个QALY。成本每QALY随更年轻出生队列而降低,1988-1992年出生加拿大人在45岁起始筛查时成本为每QALY 762加元,40岁起始为每QALY 2 622加元。

要点

  • 45岁起始FIT筛查较50岁起始减少12 188例结直肠癌病例和5 261例死亡。
  • 40岁起始筛查减少18 135例病例和7 988例死亡,增加150 373个QALY。
  • 1988-1992年出生者45岁起始筛查成本为每QALY 762加元,40岁起始为2 622加元。

核心结论

  • 该经济评价微模拟模型研究发现,更早筛查可能减轻结直肠癌疾病负担并以适度成本为加拿大人口增加生命年。
  • 指南改变提示加拿大更早结直肠癌筛查可能合理,但有必要评估对结肠镜容量的影响。

研究设计与样本

  • 经济评价计算研究,使用OncoSim平台进行微模拟建模。
  • 纳入4个出生队列(1973-1977、1978-1982、1983-1987、1988-1992),代表加拿大人口并考虑年轻出生队列结直肠癌发病率增加的已记录效应。
  • 比较每两年一次粪便免疫化学检测(FIT)筛查起始年龄45岁或40岁与50岁的关联。

主要发现

  • 45岁起始筛查较50岁起始在40年期间净减少12 188例结直肠癌病例、5 261例结直肠癌死亡,并增加92 112个质量调整生命年(QALY)。
  • 40岁起始筛查减少18 135例结直肠癌病例、7 988例结直肠癌死亡,增加150 373个QALY。
  • 成本每QALY随更年轻出生队列而降低,1988-1992年出生加拿大人在45岁起始筛查时成本为每QALY 762加元,40岁起始为每QALY 2 622加元。
  • 尽管筛查及相关治疗干预费用随更早筛查增加,但管理结直肠癌的总体医疗系统费用下降。

临床怎么用

  • 作者认为指南改变提示加拿大更早结直肠癌筛查可能合理,但有必要评估对结肠镜容量的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Recent US guideline updates have advocated for colorectal cancer (CRC) screening to begin at age 45 years in average-risk adults, whereas Canadian screening programs continue to begin screening at age 50 years. Similarities in early-onset CRC rates in Canada and the US warrant discussion of earlier screening in Canada, but there is a lack of Canadian-specific modeling data to inform this. OBJECTIVE: To estimate the association of a lowered initiation age for CRC screening by biennial fecal immunochemical test (FIT) with CRC incidence, mortality, and health care system costs in Canada. DESIGN, SETTING, AND PARTICIPANTS/EXPOSURES: This economic evaluation computational study used microsimulation modeling via the OncoSim platform. MAIN OUTCOMES AND MEASURES: Modeled rates of CRC incidence, mortality, and health care costs in Canadian dollars. RESULTS: This analysis included 4 birth cohorts (1973-1977, 1978-1982, 1983-1987, and 1988-1992) representative of the Canadian population accounting for previously documented effects of increasing CRC incidence in younger birth cohorts. Screening initiation at age 45 years resulted in a net 12 188 fewer CRC cases, 5261 fewer CRC deaths, and an added 92 112 quality-adjusted life-years (QALYs) to the cohort population over a 40-year period relative to screening from age 50 years. Screening initiation at age 40 years yielded 18 135 fewer CRC cases, 7988 fewer CRC deaths, and 150 373 QALYs. The cost per QALY decreased with younger birth cohorts to a cost of $762 per QALY when Canadians born in 1988 to 1992 began screening at age 45 years or $2622 per QALY with screening initiation at age 40 years. Although costs associated with screening and resulting therapeutic interventions increased with earlier screening, the overall health care system cost of managing CRC decreased. CONCLUSIONS AND RELEVANCE: This economic evaluation study using microsimulation modeling found that earlier screening may reduce CRC disease burden and add life-years to the Canadian population at a modest cost. Guideline changes suggesting earlier CRC screening in Canada may be justified, but evaluation of the resulting effects on colonoscopy capacity is necessary.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Kalyta A, Ruan Y, Telford JJ, et al. Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim. JAMA Oncol. 2023. PMID: 37471076. doi:10.1001/jamaoncol.2023.2312

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。